alprazolam has been researched along with Chronic Kidney Diseases in 1 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " If confirmed, this could have major implications for drug dosing in persistently inflamed patients." | 1.38 | Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation. ( Bertilsson, L; Carrero, JJ; Diczfalusy, U; Heimbürger, O; Lindholm, B; Molanaei, H; Odar-Cederlöf, I; Qureshi, AR; Stenvinkel, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molanaei, H | 1 |
| Stenvinkel, P | 1 |
| Qureshi, AR | 1 |
| Carrero, JJ | 1 |
| Heimbürger, O | 1 |
| Lindholm, B | 1 |
| Diczfalusy, U | 1 |
| Odar-Cederlöf, I | 1 |
| Bertilsson, L | 1 |
1 other study available for alprazolam and Chronic Kidney Diseases
| Article | Year |
|---|---|
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
Topics: Adult; Aged; Algorithms; Alprazolam; Anti-Anxiety Agents; Biomarkers; Biotransformation; C-Reactive | 2012 |